Home
About
Overview
Sharing Data
ORCID
Help
History (71)
Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series.
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer.
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.
RLIP: A necessary transporter protein for translating oxidative stress into pro-obesity and pro-carcinogenic signaling.
Targeting the MET gene for the treatment of non-small-cell lung cancer.
See All 71 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the MET gene for the treatment of non-small-cell lung cancer.
Targeting the MET gene for the treatment of non-small-cell lung cancer. Crit Rev Oncol Hematol. 2014 Feb; 89(2):284-99.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Drug Resistance, Neoplasm
ErbB Receptors
Humans
Lung
Lung Neoplasms
Molecular Targeted Therapy
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
authors with profiles
Marina Chiara Garassino